The NIH is expediting the safety testing of Ebola vaccines that could protect thousands from contracting the deadly virus. The trial will begin this week and will involve human subjects.
The NIH is expediting the safety testing of Ebola vaccines that could protect thousands from contracting the deadly virus. The trial will begin this week and will involve human subjects.
Share this Article
Recommended